KRAS G12D inhibitor 22
Product Specifications
Target
Ras
Related Pathways
MAPK
Bioactivity
KRAS G12D inhibitor 22 (compound 6) is a KRAS mutation inhibitor with high antitumor activity (IC50 < 100 nM), excellent selectivity, and low toxicity. It is applicable in breast cancer research.
Shipping Conditions
Cool pack
Storage Temperature
-20°C
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog
ELI-53257m 96 Tests
Mouse SH2 domain-containing protein 4A, Sh2d4a ELISA KIT
Sign In for Pricing
View Details